Viking Therapeutics Stock In The News
| VKTX Stock | USD 64.93 1.08 1.69% |
The overall news coverage of Viking Therapeutics from major news outlets shows bullish sentiment on 46 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Viking Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Viking Therapeutics. The specific impact of Viking Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Viking Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Viking Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Viking Therapeutics Backtesting and Viking Therapeutics Hype Analysis. For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.
Viking |
Viking Therapeutics Today Top News and Investor Outlook
Viking Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Viking and other traded companies coverage. We help investors stay connected with Viking headlines for the 24th of April to make an informed investment decision based on correlating the impacts of news items on Viking Stock performance. Please note that trading solely based on the Viking Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.Viking Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Viking earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Viking Therapeutics that are available to investors today. That information is available publicly through Viking media outlets and privately through word of mouth or via Viking internal channels. However, regardless of the origin, that massive amount of Viking data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Viking Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Viking Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Viking Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Viking Therapeutics alpha.
Viking Largest EPS Surprises
Earnings surprises can significantly impact Viking Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-04-27 | 2022-03-31 | -0.19 | -0.21 | -0.02 | 10 | ||
2021-04-28 | 2021-03-31 | -0.17 | -0.19 | -0.02 | 11 | ||
2020-10-28 | 2020-09-30 | -0.15 | -0.13 | 0.02 | 13 | ||
2019-08-01 | 2019-06-30 | -0.09 | -0.11 | -0.02 | 22 | ||
2019-05-02 | 2019-03-31 | -0.09 | -0.07 | 0.02 | 22 | ||
2018-08-09 | 2018-06-30 | -0.11 | -0.13 | -0.02 | 18 |
Viking Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Viking Therapeutics Stock. Current markets are strongly bullish. About 80% of major world exchanges and indexes are currently up. See today's market update for more information.
22nd of April 2024
Looking At Viking Therapeuticss Recent Unusual Options Activity at benzinga.com
17th of April 2024
Acquisition by Brian Lian of 150000 shares of Viking Therapeutics subject to Rule 16b-3 at finance.yahoo.com
10th of April 2024
What Makes Viking Therapeutics an Attractive Potential Opportunity at finance.yahoo.com
9th of April 2024
Better Buy CRISPR Therapeutics Vs. Viking Therapeutics at fool.com
8th of April 2024
Viking Therapeutics Is Great. Heres Why You Shouldnt Buy It. at fool.com
5th of April 2024
Better Booming Biotech Stock Madrigal Pharmaceuticals vs. Viking Therapeutics at finance.yahoo.com
4th of April 2024
1 Brand-New Reason to Buy Viking Therapeutics Stock Now at fool.com
2nd of April 2024
The 3 Best Biotech Stocks to Buy in April 2024 at investorplace.com
26th of March 2024
Viking Therapeutics says its experimental tablet reduced weight in early-stage study at finance.yahoo.com
20th of March 2024
Zacks Investment Ideas feature highlights Apple, Alphabet, Eli Lilly, Novo Nordisk and Vik... at finance.yahoo.com
7th of March 2024
Novos latest obesity pill spurs major weight loss in small trial at finance.yahoo.com
Viking Therapeutics Investors Sentiment
The influence of Viking Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Viking. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Viking Therapeutics' public news can be used to forecast risks associated with an investment in Viking. The trend in average sentiment can be used to explain how an investor holding Viking can time the market purely based on public headlines and social activities around Viking Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Viking Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Viking Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Viking Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Viking Therapeutics.
Viking Therapeutics Implied Volatility | 132.49 |
Viking Therapeutics' implied volatility exposes the market's sentiment of Viking Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Viking Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Viking Therapeutics stock will not fluctuate a lot when Viking Therapeutics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Viking Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Viking Therapeutics' short interest history, or implied volatility extrapolated from Viking Therapeutics options trading.
Check out Viking Therapeutics Backtesting and Viking Therapeutics Hype Analysis. For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Viking Stock analysis
When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Viking Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viking Therapeutics. If investors know Viking will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viking Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.91) | Return On Assets (0.23) | Return On Equity (0.35) |
The market value of Viking Therapeutics is measured differently than its book value, which is the value of Viking that is recorded on the company's balance sheet. Investors also form their own opinion of Viking Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viking Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viking Therapeutics' market value can be influenced by many factors that don't directly affect Viking Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viking Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viking Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viking Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.